Does the Collaborative Consensus Guidance Statement Put the Exercise ‘Cart' Before the Pacing and Pharmacological ‘Horses' in Long COVID/PASC?

PM&R ◽  
2021 ◽  
Author(s):  
Simon Décary ◽  
Darren Brown ◽  
Todd E. Davenport ◽  
Etienne Ngeh ◽  
Keyword(s):  
Author(s):  
Akash Shukla ◽  
Ananta Shreshtha ◽  
Amar Mukund ◽  
Chhagan Bihari ◽  
C. E. Eapen ◽  
...  

PM&R ◽  
2021 ◽  
Author(s):  
Joseph E. Herrera ◽  
William N. Niehaus ◽  
Jonathan Whiteson ◽  
Alba Azola ◽  
John M. Baratta ◽  
...  

BMJ Open ◽  
2017 ◽  
Vol 7 (8) ◽  
pp. e017906 ◽  
Author(s):  
Amy Theresa Page ◽  
Rhonda Marise Clifford ◽  
Kathleen Potter ◽  
Liza Seubert ◽  
Andrew J McLachlan ◽  
...  

ObjectivesThe Medication Appropriateness Tool for Comorbid Health conditions in Dementia (MATCH-D) criteria provide expert consensus guidance about medication use for people with dementia. This study aimed to identify enablers and barriers to implementing the criteria in practice.SettingParticipants came from both rural and metropolitan communities in two Australian states.ParticipantsFocus groups were held with consumers, general practitioners, nurses and pharmacists. Outcomes: data were analysed thematically.ResultsNine focus groups were conducted. Fifty-five participants validated the content of MATCH-D, appraising them as providing patient-centred principles of care. Participants identified potential applications (including the use of MATCH-D as a discussion aid or educational tool for consumers about medicines) and suggested supporting resources.ConclusionParticipants provided insights into applying MATCH-D in practice and suggested resources to be included in an accompanying toolkit. These data provide external validation of MATCH-D and an empiric basis for their translation to practice. Following resource development, we plan to evaluate the feasibility and efficacy of implementation in practice.


Author(s):  
RJ Hicks ◽  
C Dromain ◽  
W W de Herder ◽  
FP Costa ◽  
C M Deroose ◽  
...  

2019 ◽  
Vol 90 (3) ◽  
pp. e15.1-e15
Author(s):  
SP Mollan ◽  
B Davis ◽  
NC Silver ◽  
S Shaw ◽  
C Malucci ◽  
...  

ObjectivesThe aim was to capture interdisciplinary expertise from a large group of clinicians, reflecting practice from across the UK and further, to inform subsequent development of a national consensus guidance for optimal management of Idiopathic Intracranial Hypertension.DesignConsensus guideline critically reviewed by the Association of British Neurologists, British Association for the Study of Headache, the Society of British Neurological Surgeons and the Royal College of Ophthalmologists.SubjectsAn initial UK survey of attitudes and practice in IIH was sent to a wide group of physicians and surgeons.MethodsBetween September 2015 and October 2017 a specialist interest group including neurology, neurosurgery, neuro-radiology, ophthalmology, nursing, primary care doctors, and patient representatives met. A comprehensive systematic literature review was performed to assemble the foundations of the statements.ResultsOver twenty questions were constructed: One based on the diagnostic principles for optimal investigation of papilloedema and twenty-one for the management of IIH. 3 main principles were identified:to treat the underlying disease;to protect the vision andto minimise the headache morbidity.Statements presented provide insight to uncertainties in IIH where research opportunities exist.ConclusionsIn collaboration with many different specialists, professions and patient representatives we have developed guidance statements for the investigation and management of adult IIH.


2017 ◽  
Vol 131 (12) ◽  
pp. 1131-1141 ◽  
Author(s):  

AbstractBackground:Epistaxis is a common condition that can be associated with significant morbidity, and it places a considerable burden on our healthcare system. This national audit of management sought to assess current practice against newly created consensus recommendations and to expand our current evidence base.Methods:The management of epistaxis patients who met the inclusion criteria, at 113 registered sites across the UK, was compared with audit standards during a 30-day window. Data were further utilised for explorative analysis.Results:Data for 1826 cases were uploaded to the database, representing 94 per cent of all cases that met the inclusion criteria at participating sites. Sixty-two per cent of patients were successfully treated by ENT clinicians within 24 hours. The 30-day recurrent presentation rate across the dataset was 13.9 per cent. Significant event analysis revealed an all-cause 30-day mortality rate of 3.4 per cent.Conclusion:Audit findings demonstrate a varying alignment with consensus guidance, with explorative analysis countering some previously well-established tenets of management.


2015 ◽  
Vol 23 (5) ◽  
pp. 460-473 ◽  
Author(s):  
FD Richard Hobbs ◽  
Clare J Taylor ◽  
Geert Jan Geersing ◽  
Frans H Rutten ◽  
Judith R Brouwer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document